SCHEMBL31002952

SCHEMBL31002952

COc1cc(C2(O)CN(c3nc4c(c(NC5(CO)CCC5)n3)[S@+]([O-])CC4)C2)ccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31084100 0.94 PDE5A (0.32) —
SCHEMBL31084103 0.92 — —
SCHEMBL31084089 0.88 — —
SCHEMBL31083993 0.87 PIK3R1 (0.31) —
SCHEMBL31002943 0.86 — —
SCHEMBL31084088 0.86 ALDH1A1 (0.35) —
SCHEMBL31084074 0.82 PIK3R1 (0.32) —
SCHEMBL31083977 0.82 PIK3R1 (0.31) —
SCHEMBL31084034 0.81 TACR2 (0.32) —
SCHEMBL31084027 0.81 TRPV3 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4674852-A1 PREPARATION METHOD FOR AND USE OF DIHYDROTHIENOPYRIMIDINE DERIVATIVE Innovstone Therapeutics Limited (CN) 2026-01-07 — — EP disclosed
CN-118871444-A Preparation method and application of dihydro-thienopyrimidine derivative 上海翊石医药科技有限公司 2024-10-29 — — CN disclosed
WO-2024179493-A1 PREPARATION METHOD FOR AND USE OF DIHYDROTHIENOPYRIMIDINE DERIVATIVE 上海翊石医药科技有限公司 2024-09-06 — — WO disclosed
CN-118146236-A Substituted dihydrothienoazaheteroaryl derivatives, methods of preparation and use of prodrugs thereof 上海翊石医药科技有限公司 2024-06-07 — — CN disclosed
Send feedback